Dr. HernAndez Guerra de Aguilar

Medico Digestivo. Gastroenterologo y Hepatologo en Tenerife

MEDICINA DIGESTIVA

 

Consulta médica en Santa Cruz de Tenerife especializada en enfermedades del Aparato Digestivo con atención integral y personalizada

Publicaciones internacionales...(saber más)

Contribution of Cyclooxygenase End Products and Oxidative Stress to Intrahepatic Endothelial Dysfunction in Early Non-Alcoholic Fatty Liver Disease.Gonzalez-Paredes FJ, Hernández Mesa G, Morales Arraez D, Marcelino Reyes R, Abrante B, Diaz-Flores F, Salido E, Quintero E, Hernández-Guerra M. PLoS One. 2016 May 26;11(5)

Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury.Medina-Caliz I, Robles-Diaz M, Garcia-Muñoz B, Stephens C, Ortega-Alonso A, Garcia-Cortes M, González-Jimenez A, Sanabria-Cabrera JA, Moreno I, Fernandez MC, Romero-Gomez M, Navarro JM, Barriocanal AM, Montane E, Hallal H, Blanco S, Soriano G, Roman EM, Gómez-Dominguez E, Castiella A, Zapata EM, Jimenez-Perez M, Moreno JM, Aldea-Perona A, Hernández-Guerra M, Prieto M, Zoubek ME, Kaplowitz N, Lucena MI, Andrade RJ; Spanish DILI registry.. J Hepatol. 2016 Sep;65(3):532-42

Risk of Advanced Neoplasia in First-Degree Relatives with Colorectal Cancer: A Large Multicenter Cross-Sectional Study.Quintero E, Carrillo M, Leoz ML, Cubiella J, Gargallo C, Lanas A, Bujanda L, Gimeno-García AZ, Hernández-Guerra M, Nicolás-Pérez D, Alonso-Abreu I, Morillas JD, Balaguer F, Muriel A; Oncology Group of the Asociación Española de Gastroenterología (AEG).. PLoS Med. 2016 May 3;13(5)

Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis.Abraldes JG, Villanueva C, Aracil C, Turnes J, Hernandez-Guerra M, Genesca J, Rodriguez M, Castellote J, García-Pagán JC, Torres F, Calleja JL, Albillos A, Bosch J; BLEPS Study Group.. Gastroenterology. 2016 May;150(5):1160-1170.

Application of the Barcelona Clinic Liver Cancer therapeutic strategy and impact on survival. Hernández-Guerra M, Hernández-Camba A, Turnes J, Ramos LM, Arranz L, Mera J, Crespo J, Quintero E. United European Gastroenterol J. 2015 Jun;3(3):284-93

Profiles and clinical management of hepatitis C patients in Spain: disHCovery study. Buti M, Franco A, Carmona I, Sánchez-Ruano JJ, Sansó A, Berenguer M, García-Buey L, Hernández-Guerra M, Morillas RM, Ledesma F, Esteban R; disHCovery Study Group.. Rev Esp Quimioter. 2015 Jun;28(3):145-53

High efficacy and safety of triple therapy in HCV genotype 1 and moderate fibrosis: a multicenter study of clinical practice in Spain.Crespo J, Diago M, Cabezas J, Berenguer M, Broquetas T, Serra MÁ, Morillas R, García-Samaniego J, Calleja JL, Sánchez JJ, Lens S, Soto-Fernández S, Sacristán B, Fernández I, López-Núñez C, Buti M, Romero-Gómez M, Sáez-Royuela F, Fernández C, Jorquera F, Sánchez-Antolín G, Pascasio JM, Cuadrado A, Hernández-Guerra M. Ann Hepatol. 2015 Jul-Aug;14(4):477-86.

Triple therapy in cirrhotic patients and those with advanced fibrosis: relevant aspects in clinical practice. Albillos A, Luis Calleja J, Molina E, Planas R, Romero-Gómez M, Turnes J, Hernández-Guerra M. Gastroenterol Hepatol. 2014 Jul;37 Suppl 1:13-22

Therapeutic decisions in the treatment of hepatocellular carcinoma and patterns of sorafenib use. Results of the international observational GIDEON trial in Spain. Turnes J, Díaz R, Hernandez-Guerra M, Gómez M, Castells L, Bustamante J, Espinosa MD, Fernández-Castroagudín J, Serrano T, Rendón P, Andrade R, Salgado M, Arenas J, Vergara M, Sala M, Polo BA, Granizo IM, Gonzálvez ML, Viudez A. Gastroenterol Hepatol. 2015 Apr;38(4):263-73

Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening. Quintero E, Carrillo M, Gimeno-García AZ, Hernández-Guerra M, Nicolás-Pérez D, Alonso-Abreu I, Díez-Fuentes ML, Abraira V. Gastroenterology. 2014 Nov;147(5):1021-30

Role of gap junctions modulating hepatic vascular tone in liver cirrhosis. Hernández-Guerra M, González-Méndez Y, de Ganzo ZA, Salido E, García-Pagán JC, Abrante B, Malagón AM, Bosch J, Quintero E. Liver Int . 2013 Dec 18

Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury. Robles-Diaz M, Lucena MI, Kaplowitz N, Stephens C, Medina-Cáliz I, González-Jimenez A, Ulzurrun E, Gonzalez AF, Fernandez MC, Romero-Gómez M, Jimenez-Perez M, Bruguera M, Prieto M, Bessone F, Hernandez N, Arrese M, Andrade RJ; Spanish DILI Registry.; SLatinDILI Network.; Safer and Faster Evidence-based Translation Consortium.. Gastroenterology. 2014 Jul;147(1):109-118

Rebleeding prophylaxis improves outcomes in patients with hepatocellular carcinoma. A multicenter case-control study. Ripoll C, Genescà J, Araujo IK, Graupera I, Augustin S, Tejedor M, Cirera I, Aracil C, Sala M,Hernandez-Guerra M, Llop E,scorsell A, Catalina MV, Cañete N, Albillos A, Villanueva C, Abraldes JG, Bañares R, Bosch J. Hepatology . 2013 Dec;58(6):2079-88

Risk of advanced proximal neoplasms according to distal colorectal findings: comparison of sigmoidoscopy-based strategies. Castells A, Bessa X, Quintero E, Bujanda L, Cubiella J, Salas D, Lanas A, Carballo F, Morillas JD, Hernández C, Jover R, Montalvo I, Arenas J, Cosme A, Hernández V, Iglesias B, Castro I, Cid L, Sala T, Ponce M, Andrés M, Teruel G, Peris A, Roncales MP, González-Rubio F, Seoane-Urgorri A, Grau J, Serradesanferm A, Pellisé M, Ono A, Cruzado J, Pérez-Riquelme F, Alonso-Abreu I, Carrillo-Palau M, de la Vega-Prieto M, Iglesias R, Amador J, Blanco JM, Sastre R, Ferrándiz J, González-Hernández MJ, Andreu M; COLONPREV study investigatorsJ Natl Cancer Inst . 2013 Jun 19;105(12):878-86

Hepatitis C virus-infected patients with a history of epileptic fits can and should be treated with standard therapy. González-Mendez Y, Hernández-Guerra M, Turnes J, Abreu I, García D, Quintero E. Gastroenterol Hepatol . 2013 Aug-Sep;36(7):494-5

Modifiable endoscopic factors that influence the adenoma detection rate in colorectal cancer screening colonoscopies. Jover R, Zapater P, Polanía E, Bujanda L, Lanas A, Hermo JA, Cubiella J, Ono A, González-Méndez Y, Peris A, Pellisé M, Seoane A, Herreros-de-Tejada A, Ponce M, Marín-Gabriel JC, Chaparro M, Cacho G, Fernández-Díez S, Arenas J, Sopeña F, de-Castro L, Vega-Villaamil P, Rodríguez-Soler M, Carballo F, Salas D, Morillas JD, Andreu M, Quintero E, Castells A; COLONPREV study investigatorsGastrointest Endosc . 2013 Mar;77(3):381-389

Chronic intermittent hypoxia aggravates intrahepatic endothelial dysfunction in cirrhotic rats. Hernández-Guerra M, de Ganzo ZA, González-Méndez Y, Salido E, Abreu P, Moreno M, Felipe V, Abrante B, Quintero E. Hepatology . 2013 Apr;57(4):1564-74.

Immunogenicity and acceptance of influenza A (H1N1) vaccine in a cohort of chronic hepatitis C patients receiving pegylated-interferon treatment. Hernández-Guerra M, González-Méndez Y, de Molina P, Gimeno-García AZ, Carrillo M, Casanova C, Pumarola T, Jimenez A, Hernández-Porto M, Torres A, Quintero E. PLoS One . 2012;7(11)

Portal hypertension: recommendations for evaluation and treatment: consensus document sponsored by the Spanish Association for the Study of the Liver (AEEH) and the Biomedical Research Network Center for Liver and Digestive Diseases(CIBERehd)]. Bosch J, Abraldes JG, Albillos A, Aracil C, Bañares R, Berzigotti A, Calleja JL, de la Peña J, Escorsell A, García-Pagán JC, Genescà J, Hernández-Guerra M, Ripoll C, Planas R, Villanueva C. Gastroenterol Hepatol . 2012 Jun-Jul;35(6):421-50

Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. Quintero E, Castells A, Bujanda L, Cubiella J, Salas D, Lanas Á, Andreu M, Carballo F, Morillas JD, Hernández C, Jover R, Montalvo I, Arenas J, Laredo E, Hernández V, Iglesias F, Cid E, Zubizarreta R, Sala T, Ponce M, Andrés M, Teruel G, Peris A, Roncales MP, Polo-Tomás M, Bessa X, Ferrer-Armengou O, Grau J, Serradesanferm A, Ono A, Cruzado J, Pérez-Riquelme F, Alonso-Abreu I, de la Vega-Prieto M, Reyes-Melian JM, Cacho G, Díaz-Tasende J, Herreros-de-Tejada A, Poves C, Santander C, González-Navarro A; COLONPREV Study Investigators. N Engl J Med . 2012 Feb 23;366(8):697-706

EN-Vie Study Group. Proteomic analysis reveals that apolipoprotein A1 levels are decreased in patients with Budd-Chiari syndrome. Talens S, Hoekstra J, Dirkx SP, Darwish Murad S, Trebicka J, Elias E, Primignani M, García-Pagán JC, Valla DC, Janssen HL, Leebeek FW, Rijken DC;>ENVIE investigators. J Hepatol . 2011 May;54(5):908-14

Intraabdominal mass with difficult diagnosis: Solitary fibrous tumor. Alonso I, Hernández-Guerra M, González Y, Gimeno-García A, Méndez R, Malagón A, Quintero Carrión E. Gastroenterol Hepatol . 2010 Apr;33(4):303-6

Diagnostic accuracy of immunochemical versus guaiac faecal occult blood tests for colorectal cancer screening. Parra-Blanco A, Gimeno-García AZ, Quintero E, Nicolás D, Moreno SG, Jiménez A, Hernández-Guerra M, Carrillo-Palau M, Eishi Y, López-Bastida J. .J Gastroenterol . 2010 Jul;45(7):703-12

Impaired fibrinolysis as a risk factor for Budd-Chiari syndrome. Hoekstra J, Guimarães AH, Leebeek FW, Darwish Murad S, Malfliet JJ, Plessier A, Hernandez-Guerra M, Langlet P, Elias E, Trebicka J, Primignani M, Garcia-Pagan JC, Valla DC, Rijken DC, Janssen HL; European Network for Vascular Disorders of the Liver (EN-Vie). .Blood . 2010 Jan 14;115(2):388-95

Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study. Plessier A, Darwish-Murad S, Hernandez-Guerra M, Consigny Y, Fabris F, Trebicka J, Heller J, Morard I, Lasser L, Langlet P, Denninger MH, Vidaud D, Condat B, Hadengue A, Primignani M, Garcia-Pagan JC, Janssen HL, Valla D; European Network for Vascular Disorders of the Liver (EN-Vie). Hepatology . 2010 Jan;51(1):210-8.

Etiology, management, and outcome of the Budd-Chiari syndrome. Murad SD, Plessier A, Hernandez-Guerra M, et al; EN-Vie (European Network for Vascular Disorders of the Liver). Ann Intern Med. 2009 Aug 4;151(3):167-75.

Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex . Lucena MI, Andrade RJ, Kaplowitz N,et al; Spanish Group for the Study of Drug-Induced Liver Disease. Hepatology. 2009 Jun;49(6):2001-9.

Screening for familial colorectal cancer with a sensitive immunochemical fecal occult blood test: a pilot study. Gimeno-García AZ, Quintero E, Nicolás-Pérez D, Hernández-Guerra M, Parra-Blanco A, Jiménez-Sosa A. Eur J Gastroenterol Hepatol. 2009 Mar 20

Extrahepatic portal vein thrombosis. Garcia-Pagán JC, Hernández-Guerra M, Bosch J. Semin Liver Dis. 2008 Aug;28(3):282-92.

Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertension. M. Hernández-Guerra, JC. García-Pagán, J. Turnes, P. Bellot, R. Deulofeu, JG. Abraldes, J. Bosch. . Hepatology 2006;43(3):485-491.

Systemic hemodynamics, neurohumoral systems and plasma volume in severe Budd-Chiari patients. M. Hernández-Guerra, E. López, P. Bellot et al. Hepatology 2006 43(1):27-33 .

Influence of beta-2 adrenergic receptor gene polymorphism on the hemodynamic response to propranolol in patients with cirrhosis. Turnes, M. Hernandez-Guerra, JG. Abraldes et al. Hepatology 2006;43(1):34-41.

Four cases with portal hypertension and mieloid metaplasia. A. Larran, JG. Abraldes, F. Cervantes, M. Hernandez-Guerra et al. . Am J Gastroenterol 2005;100(10):2355-8.

Pharmacological reduction in portal hypertension and long term risk of variceal bleeding. Turnes, J.C.García-Pagán, J. Gonzalez-Abraldes, M. Hernández-Guerraet al. Am J Gastroenterol 2006;101:1-7.

Increased hepatic resistance: A new target in the pharmacological therapy of portal hypertension. M. Hernández-Guerr, J.C. García-Pagán, J. Bosch. J Clin Gastroenterol. 2005;39:s131-7.

PTFE-covered stents improve TIPS patency in Budd-Chiari Syndrome. M. Hernández-Guerra, J. Turnes, P. Rubinstein et al. Hepatology 2004;40:1197-1202.

Recomendaciones en el manejo diagnóstico y terapéutico de enfermos con síndrome de Budd-Chiari. M. Hernández-Guerra, J.C. García-Pagán et al. Gastroenterologia y Hepatologia 2004;27:473-479.

Are there predictive factors of severe liver fibrosis in morbidly obese patients with non-alcoholic steatohepatitis?. J Crespo, P Fernández-Gil, M Hernández-Guerra, A Cayón, M Mayorga, A Domínguez-Díez, JC Fernández Escalante, F Pons-Romero.Obesity Surgery 2001; 11(3): 254-7.

Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients. J Crespo, A Cayón, P Fernández-Gil,M Hernández-Guerr, M Mayorga, A Domínguez-Díez, JC Fernändez-Escalante, F Pons-Romero. Hepatology 2001; 34(6): 1158-63.

Impact of physician specialty on the cost of nonvariceal upper GI bleeding care. Pardo A, Durández R, Hernández M, Pizarro A, Hombrados M, Jiménez A, Planas R, Quintero E. Am J Gastroenterol 2002 Jun;97(6):1535-42.

Formación en centros de reconocido prestigio

Hospital Universitario de Canarias

Hospital de Navarra

Hospital Virgen del Camino

Clinica Universidad de Navarra

Hospital Universitario Marques de Valdecilla

Hospital Clinico de Barcelona

Hospital de Edinburgo